Skip to main content

Dr. Dawson Born

Adherence to Clinical Surveillance Guidelines in von Hippel-Lindau (vHL) disease: Evaluating the impact of a Coordinated Care Centre Implementation in Canada

Dr Xin (Cynthia) Ye

A Retrospective Study Demonstrating Higher Completion Rates of Parallel Germline Testing vs Sequential Ordering After Tumor BRCA1/2 Mutation Detection

Dr. Heather Halperin

Analysis of Young Onset Colorectal Cancer (YOCRC): Implications for Research and Clinical Practice

Dr. Graydon Arthur

Characterizing BRCA1/2-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Clinical Features, Outcomes, and Germline Testing Patterns

Dr. Patsy Lee

Impact of Time of Infusion of Immunotherapy on Efficacy in Metastatic Urothelia Cancer

Dr. Sarah Yeo

Incidence of Chronic Immune Related Adverse Events (irAEs) in patients with advanced Melanoma Treated with immune Checkpoint Inhibitors in British Columbia

Dr. Erin McAndrew

Optimizing Oral Anticancer Drug Prescribing and Dispensing at BC Cancer Vancouver Centre: First Month Audit Results of a Quality Improvement Study

Dr. Hyejee Ohm

PANNTHR: A Phase I Study of Abemaciclib and Niraparib as Neoadjuvant Therapy in HR+HER2 Breast Cancer

Dr. Faisal Alsadoun

Real World Outcomes and Toxicity with Belzutifan in the Treatment of Von Hippel–Lindau Disease a Single Centre Canadian Experience

Dr. Chloe Lim

Real World Efficacy and Outcomes in older Adults with Advanced Anaplastic Lymphoma Kinase (ALK) – A Canadian Multicenter Experience

Dr. Andrew Jamroz

Updated Outcomes in Hodgkin Variant Richter Transformation in Chronic Lymphocytic Leukemia and small Lymphocytic Lymphoma in British Columbia